Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ROAR-DIGAP
NCT06429059Phase 2Completed
- Sponsor
- Duke University
- Start
- Jun 2024
- Primary completion
- May 2025
- Countries
- 1
01
Overview
A Phase 2 trial of astaxanthin, Protandim, melatonin, mitoquinone in amyotrophic lateral sclerosis (ALS), sponsored by Duke University. Started Jun 2024; status: completed.
02
Drugs
astaxanthinProtandimmelatoninmitoquinone
03
Conditions
amyotrophic lateral sclerosis (ALS)
Beyond the preview
Go deeper on NCT06429059.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06429059.